Table 1

Primers used in the study

Primer

Forward

Reverse

ANGPTL-4

5´-CCACTTGGGACCAGGATCAC-3´

5´-CGGAAGTACTGGCCGTTGAG-3´

Leptin

5´-GGCTTTGGCCCTATCTTTTC-3´

5´-GGAATGAAGTCCAAACCGGTG-3´

VEGF

5´-CTTGCCTTGCTGCTCTACCT-3´

5´-CTGCATGGTGATGTTGGACT-3´

EFNA3

5´-CACTCTCCCCCAGTTCACCAT-3´

5´-CGCTGATGCTCTTCTCAAGCT-3´

HIF-α

5´-CACCTCTGGACTTGCCTTTC-3´

5´-GGCTGCATCTCGAGACTTTT-3´

HIF-2α

5´-CCTTCAAGACAAGGTCTGCA-3´

5´-TTCATCCGTTTCCACATCAA-3´

18S ribosomal RNA

5´-GTAACCCGTTGAACCCCA-3´

5´-CCATCCAATCGGTAGTAGCG-3´

ANGPTL-4, angiopoietin-like-4; EFNA3, ephrin A3; HIF, hypoxia-inducible factor; VEGF, vascular endothelial growth factor.

Larsen et al. Arthritis Research & Therapy 2012 14:R180   doi:10.1186/ar3934